Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease
暂无分享,去创建一个
I. McKeith | G. Livingston | C. Katona | E. Jaros | R. Perry | D. Costa | Z. Walker | R. Walker | Lean Lee | R. Walker | C. Katona | L. Lee | L. Lee
[1] J. Trojanowski,et al. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases , 2002, Annals of neurology.
[2] Z Walker,et al. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand , 2002, Journal of neurology, neurosurgery, and psychiatry.
[3] Andrew J. Lees,et al. Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease , 2001, Neurology.
[4] A. Swann,et al. Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies , 2000, Neurology.
[5] C. Katona,et al. In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies , 1999, The Lancet.
[6] J. C. Stoof,et al. Drug-naive patients with Parkinson’s disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]β-CIT SPECT , 1997, Journal of Neurology.
[7] A. Lees,et al. The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease , 1997, Neurology.
[8] D. Brooks. PET and SPECT studies in Parkinson's disease. , 1997, Bailliere's clinical neurology.
[9] M. Sambrook,et al. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[10] J D Speelman,et al. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[11] J. Cummings,et al. Frequency of dementia in Parkinson disease. , 1996, Archives of neurology.
[12] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[13] A. Lees,et al. Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.
[14] F. Huppert,et al. CAMDEX: A Standardised Instrument for the Diagnosis of Mental Disorder in the Elderly with Special Reference to the Early Detection of Dementia , 1986, British Journal of Psychiatry.
[15] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[16] W. Oertel,et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. , 2000, Movement disorders : official journal of the Movement Disorder Society.
[17] T. Ala,et al. Clinical parkinsonism in dementia patients with substantia nigra Lewy bodies , 1999, Journal of Neural Transmission.
[18] J. C. Stoof,et al. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] S. Asenbaum,et al. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. , 1997, Journal of neural transmission. Supplementum.
[20] I. Podreka,et al. Measurement of the dopaminergic degeneration in Parkinson’s disease with [123I]β-CIT and SPECT , 1997 .
[21] K. Jellinger,et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. , 1996, Neurology.
[22] D. Brooks,et al. Core assessment program for intracerebral transplantations (CAPIT) , 1992, Movement disorders : official journal of the Movement Disorder Society.
[23] L. Berg. Clinical Dementia Rating (CDR). , 1988, Psychopharmacology bulletin.